MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$1,156,208
(11.90%↑ Y/Y)
Loss from operations
-$1,137,688
(11.51%↑ Y/Y)
Total other expense
-$18,520
(30.72%↑ Y/Y)
Net product sales
$4,283,979
(61.40%↑ Y/Y)
Interest income
$107,507
(8.27%↑ Y/Y)
Total operating
expenses
$5,421,667
(37.61%↑ Y/Y)
Interest expense
$126,027
(0.00%↑ Y/Y)
Selling, general and
administrative
$5,314,370
(38.97%↑ Y/Y)
Cost of goods sold
$101,977
(-1.97%↓ Y/Y)
Research and development
$5,320
(-54.44%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Evoke Pharma Inc (EVOK)
Evoke Pharma Inc (EVOK)